Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1970 2
1972 1
1974 3
1998 1
2018 1
2020 3
2021 1
2022 2
2023 4
2024 5
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.
Joly F, Leary A, Ray-Coquard I, Asselain B, Rodrigues M, Gladieff L, Meynard G, Abadie-Lacourtoisie S, Lebreton C, Bengrine Lefevre L, Fournel P, Largillier R, Selle F, Frenel JS, Fernandez Diez Y, Foa C, Follana P, Meunier J, Fabbro M, Hardy Bessard AC, Cojean-Zelek I, Kaczmarek E, Bonnet E, Arnaud A, Roche S, Leroy K, Just PA, Leman R, Jeanne C, Callens C, You B, Alexandre J. Joly F, et al. Among authors: jeanne c. Nat Commun. 2025 Aug 26;16(1):7950. doi: 10.1038/s41467-025-62678-x. Nat Commun. 2025. PMID: 40858558 Free PMC article. Clinical Trial.
Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).
Leman R, Cherifi F, Leheurteur M, Theret P, Pasquesoone C, Saint-Ghislain M, Bresson L, Denoyelle C, Vigneron N, Poulain L, Delepee R, Berby B, Dremaux J, Dumont A, Blanc-Fournier C, Jeanne C, Briand M, Rousseau N, Pepin LF, Deruche E, Dumont F, Leconte A, Lequesne J, Clarisse B, Joly F, Castera L, Rouzier R. Leman R, et al. Among authors: jeanne c. BMC Cancer. 2025 Jul 1;25(1):1075. doi: 10.1186/s12885-025-14423-2. BMC Cancer. 2025. PMID: 40597907 Free PMC article. Clinical Trial.
Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights.
Alsugair Z, Lépine C, Descotes F, Lanic MD, Pissaloux D, Tirode F, Lopez J, Céruse P, Philouze P, Fieux M, Wassef M, Baglin AC, Mihaela O, Castain C, Sudaka A, Uro-Coste E, Champagnac A, Costes-Martineau V, Laé M, Benzerdjeb N; REFCOR network*. Alsugair Z, et al. Hum Pathol. 2024 Oct;152:105633. doi: 10.1016/j.humpath.2024.105633. Epub 2024 Jul 30. Hum Pathol. 2024. PMID: 39089476 Free article.
The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.
Gall GL, Cherifi F, Divoux J, Florent R, Christy F, Leconte A, San C, Devillers A, Desmartin G, Lecouflet L, Clarisse B, Ballesta S, Thorel L, Dubois B, Harter V, Rousseau N, Gaichies L, Martin-Françoise S, Le Brun JF, Dolivet E, Rouzier R, Jeanne C, Blanc-Fournier C, Figeac M, Leman R, Castera L, Poulain L, Weiswald LB, Joly F. Gall GL, et al. Among authors: jeanne c. BMC Cancer. 2025 Feb 11;25(1):244. doi: 10.1186/s12885-025-13590-6. BMC Cancer. 2025. PMID: 39934735 Free PMC article.
The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.
Thorel L, Divoux J, Lequesne J, Babin G, Morice PM, Florent R, Desmartin G, Lecouflet L, Marde Alagama C, Leconte A, Clarisse B, Briand M, Rouzier R, Gaichies L, Martin-Françoise S, Le Brun JF, Denoyelle C, Vigneron N, Jeanne C, Blanc-Fournier C, Leman R, Vaur D, Figeac M, Meryet-Figuiere M, Joly F, Weiswald LB, Poulain L, Dolivet E. Thorel L, et al. Among authors: jeanne c. BMC Cancer. 2024 Jun 7;24(1):701. doi: 10.1186/s12885-024-12429-w. BMC Cancer. 2024. PMID: 38849726 Free PMC article.
Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).
Henno S, Jeanne C, Rouge TM, Genestie C, Treilleux I, Croce S, Just PA, Le Frere-Belda MA, Guinaudeau E, Penault-Llorca F, Arnould L, Mery-Lamarche E, Leroux A, Lemaire AS, Averous G, Renaud O, Charafe-Jauffret E, Bonneau C, Leaha C, Ray-Coquard I, Devouassoux-Shisheboran M. Henno S, et al. Among authors: jeanne c. Gynecol Oncol. 2022 Jun;165(3):637-641. doi: 10.1016/j.ygyno.2022.03.019. Epub 2022 Apr 4. Gynecol Oncol. 2022. PMID: 35393217 Review.
Effectiveness of bilateral tongue base mucosectomy by transoral robotic surgery or transoral laser microsurgery in combination with tonsillectomy in identifying head and neck primary cancer of unknown primary: a randomized phase 2 protocol (RoboCUP trial).
Bastit V, Lequesne J, Leconte A, Deneuve S, Mouawad F, Quak E, Jeanne C, Clarisse B, Thariat J. Bastit V, et al. Among authors: jeanne c. BMC Cancer. 2025 Mar 27;25(1):551. doi: 10.1186/s12885-025-13913-7. BMC Cancer. 2025. PMID: 40148848 Free PMC article.
31 results